Notably, as melanoma progresses, the expression of the receptor tyrosine kinase c-KIT decreases, while levels of miR-221/222 increase, indicating a negative correlation between miR-221/222 and c-KIT expression [54,56]. The gene discussed is KIT; the disease is melanoma.